Published Date: 02 Mar 2023
Although it is recognized that pain is common among nursing home residents, little attention has been paid to how this pain changes over time. A new study from the Regenstrief Institute and the Indiana University School of Nursing...
Read Full NewsPhase 3 data show dapirolizumab pegol improved remission and disease stability in lupus; a second trial and patient-reported outcomes are now underway.
Acumen Pharmaceuticals initiates a phase 2 trial extension for sabirnetug, targeting early Alzheimer disease and aiming for long-term safety insights.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 21, 2025.
A case report reveals cognitive decline and brain atrophy in a patient with NMOSD, highlighting potential subclinical neurodegeneration despite limited relapses.
A recent study confirms satralizumab's long-term safety and efficacy for treating neuromyelitis optica spectrum disorder, supporting its use as a maintenance therapy.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neural network plasticity after stroke!
At ACAAI 2025, Howell discussed sub-analytical data showing early itch and skin improvements with tapinarof cream in children with AD aged 2–17 years.
1.
Elder Abuse: Red Flags to Look Out For While Receiving Care.
2.
Many Americans unaware of links between HPV and cancers, poll reveals
3.
For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.
4.
After cancer: Study explores caring-healing modalities for survivors
5.
Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer
1.
Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia
2.
Survival Rate Dynamics in Hematologic and Solid Malignancies
3.
Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment
4.
Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies
5.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XII
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
3.
Navigating the Complexities of Ph Negative ALL - Part XI
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part X
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation